Evaluation of an Integrated Telemonitoring Surveillance System in Patients with Coronary Heart Disease
02 February 2015
accepted: 06 July 2015
22 January 2018 (online)
Objectives: Cardiovascular diseases are the most frequent cause of death in industrialized countries. Non-adherence with prescribed medication and recommended lifestyle changes significantly increases the risk of major cardiovascular events. The telemonitoring programme MyCor (Myokardinfarkt und Koronarstent Programm in Tirol) is a multi-modal intervention programme to improve lifestyle and medication management of patients with coronary heart disease (CHD). It includes patient education, self-monitoring with goal-setting and feedback, and regular clinical visits. We evaluated the MyCor telemonitoring programme regarding technical feasibility, user acceptance, patient adherence, change in health status, and change in quality of life.
Methods: A 4½-month study was conducted with two telemonitoring phases and one interim phase. The study comprised patient surveys, standardized assessment of quality of life using the MacNew questionnaire at study entry and after 4 and 18 weeks, analysis of adherence to medication and physical activity during the two telemonitoring phases, and analysis of reached goals regarding health conditions during the telemonitoring phases.
Results: Twenty-five patients (mean age: 63 years) participated in the study. Patients showed a high acceptance of the MyCor tele-monitoring programme. Patients reported feelings of self-control, motivation for lifestyle changes, and improved quality of life. Adherence to daily measurements was high with 86% and 77% in the two telemonitoring phases. Adherence to medication was also high with up to 87% and 80%. Pre-defined goals for physical activity were reached in up to 86% and 73% of days, respectively. Quality of life improved from 5.5 at study entry to 6.3 at the end (p< 0.01; MacNew questionnaire). Reductions in blood pressure and heart rate or an improvement in reaching defined goals could not be observed.
Conclusions: The MyCor telemonitoring programme Tirol for CHD patients has a high rate of acceptance among included patients. Critical evaluation revealed subjective benefits regarding quality of life and health status as well as high adherence rates to medication and lifestyle changes. Achieving long-term adherence and verifying clinical outcomes, however, remains an open issue. Our findings will promote further studies, addressing different strategies for an optimal mix of patient education, telemonitoring, feedback, and clinical follow-ups.
- 1 Statistik Austria Todesursachen 2012. 2014 [accessed 2015, April-24] . Available from: http:// www.statistik.at/web_de/statistiken/gesundheit/ todesursachen/todesursachen_ausgewaehlte/index.html.
- 2 Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G. et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.. Lancet 2007; 369 9562 667-678.
- 3 Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study.. Arch Intern Med 2007; 167 (016) 1798-1803.
- 4 van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, Koolen JJ, Brueren BR, Dambrink JH. et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.. J Am Coll Cardiol 2009; 53 (016) 1399-1409.
- 5 Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor.. MedGenMed 2007; 9 (03) 58.
- 6 Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA. et al. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.. Clin Cardiol 2013; 36 (012) 721-727.
- 7 Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes.. Circulation 2009; 119 (023) 3028-3035.
- 8 Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS. Impact of medication therapy discontinuation on mortality after myocardial infarction.. Arch Intern Med 2006; 166 (017) 1842-1847.
- 9 Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost.. Med Care 2005; 43 (06) 521-530.
- 10 Bosworth HB, Powers BJ, Oddone EZ. Patient self-management support: novel strategies in hypertension and heart disease.. Cardiol Clin 2010; 28 (04) 655-663.
- 11 Lyons EJ, Lewis ZH, Mayrsohn BG, Rowland JL. Behavior change techniques implemented in electronic lifestyle activity monitors: a systematic content analysis.. J Med Internet Res 2014; 16 (08) e192.
- 12 Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T.. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2010 (03) CD005182.
- 13 Kreiner K, Welte S, Modre-Osprian R, Fetz B, Heidt A, Ammenwerth E, Pölzl G, Kastner P.. A personalized feedback system for supporting behavior change for patients after an acute myocardial infarction. In: Hayn D, Schreier G, Ammenwerth E, Hörbst A. editors. Proceedings of eHealth2015, 18.-19.6.2015, Vienna.. Amsterdam: IOS Press; 2015
- 14 DeLone W, McLean E. The DeLone and McLean Model of Information Systems Success: A Ten-Year Update.. Journal of Management Information Systems 2003; 19 (04) 9-30.
- 15 Bortz J, Döring N. Forschungsmethoden und Evaluation für Human- und Sozialwissenschaftler [Research methods and evaluation] . 3rd ed. Berlin: Springer; 2002
- 16 Hofer S, Schmid JP, Frick M, Benzer W, Laimer H, Oldridge N, Saner H. Psychometric properties of the MacNew heart disease health-related quality of life instrument in patients with heart failure.. J Eval Clin Pract 2008; 14 (04) 500-506.
- 17 Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, Stricker B, Mendis S, Hofman A. et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences.. Eur Heart J 2013; 34 (038) 2940-2948.
- 18 Buysse HE, de Moor GJ, de Maeseneer J. Introducing a telemonitoring platform for diabetic patients in primary care: will it increase the socio-digital divide?. Prim Care Diabetes 2013; 7 (02) 119-127.
- 19 Romano MF, Sardella MV, Alboni F, Russo L, Mariotti R, Nicastro I, Barletta V, Di Bello V. Is the Digital Divide an Obstacle to e-Health? An Analysis of the Situation in Europe and in Italy.. Telemed J E Health 2015; 21 (01) 24-35.
- 20 Masucci MM, Homko C, Santamore WP, Berger P, McConnell TR, Shirk G, Menapace F, Bove AA. Cardiovascular disease prevention for underserved patients using the Internet: bridging the digital divide.. Telemed J E Health 2006; 12 (01) 58-65.
- 21 Aujoulat I, d’Hoore W, Deccache A. Patient empowerment in theory and practice: polysemy or cacophony?. Patient Educ Couns 2007; 66 (01) 13-20.
- 22 McFadden E, Luben R, Wareham N, Bingham S, Khaw KT. Occupational social class, risk factors and cardiovascular disease incidence in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort.. Eur J Epidemiol 2008; 23 (07) 449-58.
- 23 Bott OJ, Marschollek M, Wolf KH, Haux R. Towards new scopes: sensor-enhanced regional health information systems - part 1: architectural challenges.. Methods Inf Med 2007; 46 (04) 476-483.